Go
Sort by:
titlesubmit dateissue date
Order:
ascendingdescending
Results:
51020406080100
Update
Now showing items 1-20 of 27
Applied mathematics and nonlinear sciences in the war on cancer
Artículo
Bevacizumab dose adjustment to improve clinical outcomes of glioblastoma.
Blood-Brain Barrier Disruption: A Common Driver of Central Nervous System Diseases.
Cancer stem cells from human glioblastoma resemble but do not mimic original tumors after <i>in vitro</i> passaging in serum-free media
Cellular Plasticity and Tumor Microenvironment in Gliomas: The Struggle to Hit a Moving Target.
Chimeric NANOG repressors inhibit glioblastoma growth in vivo in a context-dependent manner
Controlled release microspheres loaded with BMP7 suppress primary tumors from human glioblastoma
DYRK1A: the double-edged kinase as a protagonist in cell growth and tumorigenesis
EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy.
High expression of MKP1/DUSP1 counteracts glioma stem cell activity and mediates HDAC inhibitor response
Immune Profiling of Gliomas Reveals a Connection with IDH1/2 Mutations, Tau Function and the Vascular Phenotype.
Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth
Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells
Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion.
NFATc3 controls tumour growth by regulating proliferation and migration of human astroglioma cells
Novel Functions of the Neurodegenerative-Related Gene Tau in Cancer
Ocoxin Modulates Cancer Stem Cells and M2 Macrophage Polarization in Glioblastoma
ODZ1 allows glioblastoma to sustain invasiveness through a Myc-dependent transcriptional upregulation of RhoA
Oncogenic dependence of glioma cells on kish/TMEM167A regulation of vesicular trafficking.
Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma.
2021-01-15
